Biotest AG: Biotest treats first CMV-positive pregnant woman in Phase III clinical trial to prevent transmission of CMV infection to the unborn child 14.12.2021 / 07:00 The issuer is solely ...

Mothers with intrauterine transmission of human cytomegalovirus (CMV) to their newborns despite preconception immunity had higher levels of neutralizing antibodies but had weaker antibody-dependent ...

Thirty percent of pregnant women do not have CMV antibodies. One percfent of this group will contract CMV for the first time during pregnancy. Among them, 40 percent of women will have viral ...

Study participants include children up to and including 36 months who attend group child care and early childhood education settings located in Worcester and Cambridge The study will examine how CMV ...

Researchers at Tulane University have shown for the first time that mothers are much less likely to transmit a common virus known to cause miscarriages and birth defects if they are exposed to the ...

ANN ARBOR, Mich.--(BUSINESS WIRE)--CareEvolution is excited to announce that enrollment through its clinical research platform, MyDataHelps, has opened for a groundbreaking study on cytomegalovirus ...

A leading cause of birth defects is a virus that many expectant parents have never heard about. That may change soon thanks to the advocacy of parents whose children suffered birth defects due to the ...